Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Sahra Kaahiye, a respiratory therapist at Edmonton’s Glenrose Rehabilitation Hospital, gets the province's first shot of the Pfizer-BioNTech vaccine on Dec. 15.

Jason Franson/The Canadian Press

Less than a year after COVID-19 first reached its shores, Canada began vaccinating people against the virus that causes it. The federal government, provinces and First Nations have a difficult task ahead – a general vaccination that Ottawa hopes to begin by April and finish by the end of the year – but it’s already hit some snags as production slowdowns and European regulatory chaos brought Canada’s shipments to a near-standstill in late January and early February.

Here’s a primer on the rollout plans so far. You can also consult our main COVID-19 data page for the latest numbers of vaccine doses administered, nationwide and by province.


Vaccine rollouts by province

The first Newfoundlander injected: Public-health nurse Ellen Foley-Vick on Dec. 16.

Sarah Smellie/The Canadian Press

Newfoundland and Labrador

  • Official page: Check Newfoundland and Labrador’s coronavirus information page here.
  • The plan so far: The first phase of vaccinations is focused on seniors in congregate-living arrangements, people 85 and older, health-care workers and adults in remote Indigenous communities. The rollout in long-term care got off to a slow start in February as vaccine shipments from Europe slowed down.

One of the first three islanders vaccinated: Debbie Lawless, a registered nurse at a Charlottetown nursing home, on Dec. 16.

Brian McInnis/The Canadian Press

Prince Edward Island

Nova Scotia

New Brunswick

The first Quebecker injected: Gisèle Lévesque, an 89-year-old resident of a Quebec City long-term care home, on Dec. 14.

PATRICK LACHANCE/MCE/AFP via Getty Images

Quebec

The first Ontarian injected: Anita Quidangen, a personal support worker at a Toronto long-term care home, on Dec. 14.

Carlos Osorio/Reuters

Ontario

  • Official page: Check Ontario’s coronavirus information page and its guide to the vaccine rollout specifically.
  • The plan so far: Winter supply shortages left Ontario lagging behind other provinces in its long-term care vaccinations, but it has been racing to catch up. An online booking system will be operational by March 15, according to Rick Hillier, the retired general in charge of the rollout. Ontarians 80 and older will be eligible to book appointments starting the third week of March. The next age cohorts are 75 and older (April 15), 70 and older (May 1), 65 and older (June 1) and 60 and older (July 1). The Ontario cabinet is still finalizing criteria for essential workers, who are likely to get vaccinated starting in May, Mr. Hillier says.

Manitoba

  • Official page: Check Manitoba’s coronavirus information page and its guide to the vaccine rollout specifically. Manitoba also has a queue calculator where you can get an estimate of where you are on the priority list.
  • The plan so far: Manitoba managed to vaccinate all long-term care residents by January and has moved on to other priority groups in health care, Indigenous communities and old-age cohorts. Indigenous people 75 and older and all Manitobans 95 and older are currently eligible: A call centre is available (1-844-626-8222) to screen people before booking appointments.

Saskatchewan

Alberta

B.C.

Territories

  • Official pages: Check the coronavirus information pages for Nunavut, the Northwest Territories and Yukon.
  • The plan so far: All three territories are using Moderna’s vaccine almost exclusively, since it is easier to transport and store in the North than Pfizer-BioNTech’s. Elders, front-line health workers and people in remote communities at risk of outbreaks were the first to get it. The territorial governments aim to vaccinate 75 per cent or more of their populations by March of 2021.

National overview

How do the vaccines get to where I live?

The Trudeau government has bought tens of millions of doses of various vaccines and is co-ordinating with provinces, territories and First Nations to deliver them to Canadians free of charge. The vaccines go through a central agency, the National Operations Centre, where health officials and the military organize their distribution.

The rollout of COVID-19 vaccines may follow

a similar pattern but in the initial stages the

federal government will play a more active

role because of the logistical challenges

associated with vaccines that require cold

or ultracold infrastructure.

ALTA, SASK., ONT., QUE. AND N.B.

MANUFACTURER

CENTRAL DEPOT

PHARMACY WHOLESALE DISTRIBUTORS AND SELF

DISTRIBUTING CHAINS

REGIONAL DEPOT

ADMINISTRATION

SITES AND

FIRST NATIONS

PROVIDERS

PHARMACIES

B.C., N.S. and N.L.

MANUFACTURER

CENTRAL DEPOT

REGIONAL DEPOTS

ADMINISTRATION SITES AND

FIRST NATIONS PROVIDERS

Man., PEI., Yukon, NWT, Nunavut, Department of National Defence and Correctional Service Canada

MANUFACTURER

CENTRAL OR

REGIONAL DEPOTS

ADMINISTRATION SITES AND

FIRST NATIONS PROVIDERS

MURAT yükselir / the globe and mail,

source: Public Heath Agency of Canada

The rollout of COVID-19 vaccines may follow a

similar pattern but in the initial stages the federal

government will play a more active role because of

the logistical challenges associated with vaccines

that require cold or ultracold infrastructure.

ALTA, SASK., ONT., QUE. AND N.B.

MANUFACTURER

CENTRAL DEPOT

PHARMACY WHOLESALE DISTRIBUTORS AND SELF

DISTRIBUTING CHAINS

REGIONAL DEPOTS

ADMINISTRATION

SITES AND

FIRST NATIONS

PROVIDERS

PHARMACIES

B.C., N.S. and N.L.

MANUFACTURER

CENTRAL DEPOT

REGIONAL DEPOTS

ADMINISTRATION SITES AND

FIRST NATIONS PROVIDERS

Man., PEI., Yukon, NWT, Nunavut, Department of National Defence and Correctional Service Canada

MANUFACTURER

CENTRAL OR

REGIONAL DEPOTS

ADMINISTRATION SITES AND

FIRST NATIONS PROVIDERS

MURAT yükselir / the globe and mail,

source:Public Heath Agency of Canada

The rollout of COVID-19 vaccines may follow a similar pattern but

in the initial stages the federal government will play a more active role

because of the logistical challenges associated with vaccines that require

cold or ultracold infrastructure.

Alta, Sask., Ont., Que. and N.B.

B.C., N.S. and N.L.

Man., PEI., Yukon, NWT, Nunavut, Department of National Defence and Correctional Service Canada

MANUFACTURER

CENTRAL DEPOT

CENTRAL DEPOT

CENTRAL OR

REGIONAL DEPOTS

PHARMACY WHOLESALE DISTRIBUTORS AND SELF

DISTRIBUTING CHAINS

REGIONAL DEPOTS

REGIONAL DEPOTS

ADMINISTRATION

SITES AND

FIRST NATIONS

PROVIDERS

ADMINISTRATION

SITES AND

FIRST NATIONS

PROVIDERS

ADMINISTRATION

SITES AND

FIRST NATIONS

PROVIDERS

PHARMACIES

MURAT yükselir / the globe and mail, source: Public Heath Agency of Canada

Which vaccine will I get?

So far, Health Canada has approved three vaccines: First Pfizer-BioNTech’s, then Moderna’s, and now Oxford-AstraZeneca’s. All three were at least 95-per-cent effective in late-stage clinical trials, but only if patients are given two doses a few weeks apart. Studies suggest those vaccines are still mostly effective against the COVID-19 variants observed so far, especially the British variant, so far the most common one.

The Pfizer-BioNTech vaccine has to be stored between -60 and -80 C, so the provinces have scrambled to get enough ultracold storage space. Moderna says its drug is stable at -20 C (a standard freezer temperature) for up to six months, and at two to eight degrees (a standard refrigerator temperature) for 30 days.

Ottawa has pre-purchased four other vaccine candidates, some of which are in a “rolling submission” process that allows Health Canada to evaluate them before all the data is gathered:

  • Janssen/Johnson & Johnson
  • Medicago/GlaxoSmithKline
  • Novavax
  • Sanofi/GlaxoSmithKline

What is Ottawa’s overall plan?

Ottawa’s initial timetable calls for three million vaccinations by the end of March, general inoculation by April and all Canadians vaccinated by December. That plan isn’t set in stone, as much will depend on global supply chains: There was much less less vaccine to go around in January and February due to supply shortages from BioNTech and Moderna.

CANADA’S VACCINE CONTRACTS

The federal government has signed contracts to buy seven COVID-19 vaccine candidates. If all of those vaccines get Health Canada authorization, then Ottawa would buy 234 million vaccine doses. The government also negotiated options that give it the right to buy 164 million more doses if it chooses to.

Doses

purchased

Options

available

VACCINE (type)

DOSAGE

STATUS

Pfizer/BioNTech (mRNA) 

(millions of doses)

Authorized

in Canada

40

36

Moderna (mRNA) 

Authorized

in Canada

40

Under Review

in Canada;

Partial phase 3

data available

AstraZeneca/Oxford U.

(Adenovirus vector)

20

Janssen/Johnson & Johnson

(Adenovirus vector)

Under Review

in Canada;

Phase 3 data

pending

10

28

NovaVax (Protein nanoparticles)

Phase 3

data pending

52

24

Medicago/GSK

(Virus-like particles with protein)

Phase 2/3

trial underway

20

56

Sanofi/GSK (Recombinant protein)

Phase 3 trial

delayed till at

least Q2 2021

52

20

CANADA’S IMMUNIZATION PLAN

By September, the federal government says they will have

enough vaccine to inoculate everyone in Canada who wants a

shot. If more vaccines are authorized, and delivered, that timeline

could be sped up.

FIRST QUARTER

SECOND QUARTER

THIRD QUARTER

38 million

vaccinated

3 million

vaccinated

Goal

23 million

vaccinated

J

F

M

A

M

J

J

A

S

Enough doses

secured for

3 million

Enough doses

secured for

13 million

Enough doses

secured for

36 million

Reality

THE GLOBE AND MAIL

CANADA’S VACCINE CONTRACTS

The federal government has signed contracts to buy seven

COVID-19 vaccine candidates. If all of those vaccines get Health

Canada authorization, then Ottawa would buy 234 million vaccine

doses. The government also negotiated options that give it the

right to buy 164 million more doses if it chooses to.

Doses

purchased

Options

available

VACCINE (type)

DOSAGE

STATUS

Pfizer/BioNTech (mRNA) 

(millions of doses)

Authorized

in Canada

40

36

Moderna (mRNA) 

Authorized

in Canada

40

Under Review

in Canada;

Partial phase 3

data available

AstraZeneca/Oxford U.

(Adenovirus vector)

20

Janssen/Johnson & Johnson

(Adenovirus vector)

Under Review

in Canada;

Phase 3 data

pending

10

28

NovaVax (Protein nanoparticles)

Phase 3

data pending

52

24

Medicago/GSK

(Virus-like particles with protein)

Phase 2/3

trial underway

20

56

Sanofi/GSK (Recombinant protein)

Phase 3 trial

delayed till at

least Q2 2021

52

20

CANADA’S IMMUNIZATION PLAN

By September, the federal government says they will have

enough vaccine to inoculate everyone in Canada who wants a

shot. If more vaccines are authorized, and delivered, that timeline

could be sped up.

FIRST QUARTER

SECOND QUARTER

THIRD QUARTER

38 million

vaccinated

3 million

vaccinated

Goal

23 million

vaccinated

J

F

M

A

M

J

J

A

S

Enough doses

secured for

3 million

Enough doses

secured for

13 million

Enough doses

secured for

36 million

Reality

THE GLOBE AND MAIL

CANADA’S VACCINE CONTRACTS

The federal government has signed contracts to buy seven COVID-19 vaccine candi-

dates. If all of those vaccines get Health Canada authorization, then Ottawa would buy

234 million vaccine doses. The government also negotiated options that give it the right

to buy 164 million more doses if it chooses to.

Doses

purchased

Options

available

VACCINE (type)

DOSAGE

STATUS

Pfizer/BioNTech (mRNA) 

(millions of doses)

Authorized

in Canada

40

36

Moderna (mRNA) 

Authorized

in Canada

40

Under Review

in Canada;

Partial phase 3

data available

AstraZeneca/Oxford U. (Adenovirus vector)

20

Janssen/Johnson & Johnson

(Adenovirus vector)

Under Review

in Canada;

Phase 3 data

pending

10

28

NovaVax (Protein nanoparticles)

Phase 3

data pending

52

24

Medicago/GSK (Virus-like particles with protein)

20

Phase 2/3

trial underway

56

Sanofi/GSK (Recombinant protein)

Phase 3 trial

delayed till at

least Q2 2021

52

20

CANADA’S IMMUNIZATION PLAN

By September, the federal government say sthey will have enough vaccine to inoculate

everyone in Canada who wants a shot. If more vaccines are authorized, and delivered,

that timeline could be sped up.

FIRST QUARTER

SECOND QUARTER

THIRD QUARTER

3 million

vaccinated

Goal

23 million

vaccinated

38 million

vaccinated

J

F

M

A

M

J

J

A

S

Enough doses

secured for

3 million

Enough doses

secured for

13 million

Enough doses

secured for

36 million

Reality

MARIEKE WALSH, IVAN SEMENIUK AND JOHN SOPINSKI / THE GLOBE AND MAIL


Compiled by Globe staff

With reports from The Canadian Press, Ivan Semeniuk and Kelly Grant


Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies